Validation of the Mayo alliance prognostic system for mastocytosis Article Swipe
Related Concepts
Alliance
Medicine
Systemic mastocytosis
Hematology
MEDLINE
Internal medicine
Immunology
Intensive care medicine
Biology
Political science
Bone marrow
Law
Biochemistry
Francesco Mannelli
,
Francesca Gesullo
,
Giada Rotunno
,
Annalisa Pacilli
,
Lisa Pieri
,
Paola Guglielmelli
,
Alessandro M. Vannucchi
·
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1038/s41408-019-0179-7
· OA: W2914459338
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1038/s41408-019-0179-7
· OA: W2914459338
this analysis allowed to confirm the general validity of risk stratification of patients with systemic mastocytosis according to the newly developed Mayo models; furthermore, we revealed its performance in predicting prognosis of intermediate category’ patients, especially using the clinical model. The proportionality between risk factors and outcome reaffirms the proof-of-principle underneath Mayo model.
Related Topics
Finding more related topics…